Table 2 Primary and secondary outcomes in the two groups

• Remifentanil consumption (ug/kg/min)

0.57 (0.49–0.64)

0.69 ((0.63–0.75))

0.016^*

• Propofol consumption (ug/kg/min)

155.5 (146–165)

171.0 (161–181)

0.02^*

• Max-FLACC pain score in PACU

4.22 (4–4.43)

4.74 (4.41–5.07)

0.02^*

• Total pethidine consumption at PACU (mg)

7.0 (6.17–7.83)

8.9 (7.84–9.96)

0.012^*

• Incidence of vomiting at PACU

2 (5.7%)

5 (14.2%)

0.42